54 results
8-K
EX-99.1
AUPH
Aurinia Pharmaceuticals Inc
2 May 24
Aurinia Pharmaceuticals Reports First Quarter 2024 Financial and Operational Results
6:03am
the holistic approach the Company takes to address environmental, social and governance priorities, including energy and emissions, addressing
8-K
EX-10.1
AUPH
Aurinia Pharmaceuticals Inc
21 Sep 23
Aurinia Board of Directors Appoints Dr. Robert T. Foster as New Board Director
4:06pm
statement, announcement or media placement (including social media) (each, a “Statement”) that constitutes an ad hominem attack on, or that otherwise … (including social media and virtual or online networks or communities), and (C) to any journalist or member of the media (including in a television, radio
8-K
EX-99.1
81gsyimkhbl4atg9
4 May 23
Aurinia Pharmaceuticals Reports First Quarter 2023 Financial and Operational Results
6:06am
DEFA14A
5jp2y92poq8vusczjh5
18 Apr 22
Additional proxy soliciting materials
7:36am
S-3ASR
EX-4.5
os6msy9drgtxxuc6o2
19 Nov 21
Automatic shelf registration
5:04pm
S-3ASR
EX-1.2
o2l 8vwha
19 Nov 21
Automatic shelf registration
5:04pm
S-3ASR
EX-4.6
0t701301 2o
19 Nov 21
Automatic shelf registration
5:04pm
8-K
EX-99.1
p0b0ba 5i
17 Aug 21
Riptide Aurinia Collaboration & License Agreement
4:07pm
S-8
EX-10.2
8g0ot2vmh0izms4w
25 Jun 21
Registration of securities for employees
4:31pm
8-K
EX-99.2
5euppwe0bceh4f
10 Jun 21
Departure of Directors or Certain Officers
4:08pm
DEF 14A
nbcs2qxn5 q2762sl1
10 May 21
Definitive proxy
4:06pm